Citations

Mayo Clinic

Clear

16255 citation(s) found for "Ha, David R".

The Glycosphingolipid, Lactosylceramide, Regulates β1-Integrin Clustering and Endocytosis
Sharma, Deepak , Brown, Jennifer C., Cheng, Zhi-jie Jey , Holicky, Eileen L., Marks, David L. , Pagano, Richard E.

Cancer Research | September 15, 2005 | Volume: 65 | Issue: 18 | Pages: 8233-8241

10.1158/0008-5472.can-05-0803 | PMID 16166299 Get It

Abstract Glycosphingolipids are known to play roles in integrin-mediated cell adhesion and migration; however, the mechanisms by which glycosphingolipids affect integrins are unknown. Here, we show that addition of the glycosphingolipid, C8-lactosylceramide (C8-LacCer), or free cholesterol to human fibroblasts at 10°C causes the formation of glycosphingolipid-enriched plasma membrane domains as shown by visualizing a fluorescent glycosphingolipid probe, BODIPY-LacCer, incorporated into the plasma membrane of living cells. Addition of C8-LacCer or cholesterol to cells initiated the clustering of β1-integrins within these glycosphingolipid-enriched domains and the activation of the β1-integrins as assessed using a HUTS antibody that only binds activated integrin. On warming to 37°C, β1-integrins were rapidly internalized via caveolar endocytosis in cells treated with C8-LacCer or cholesterol, whereas little β1-integrin was endocytosed in untreated fibroblasts. Incubation of cells with C8-LacCer or cholesterol followed by warm-up caused src activation, a reorganization of the actin cytoskeleton, translocation of RhoA GTPase away from the plasma membrane as visualized using total internal reflection fluorescence microscopy, and transient cell detachment. These studies show that LacCer can regulate integrin function both by modulating integrin clustering in microdomains and by regulating integrin endocytosis via caveolae. Our findings suggest the possibility that aberrant levels of glycosphingolipids found in cancer cells may influence cell attachment events by direct effects on integrin clustering and internalization.
PHOTOSELECTIVE POTASSIUM-TITANYL-PHOSPHATE LASER VAPORIZATION OF THE BENIGN OBSTRUCTIVE PROSTATE: OBSERVATIONS ON LONG-TERM OUTCOMES
Malek, Reza S., Kuntzman, Randall S., Barrett, David M.

Journal of Urology | September 13, 2005 | Volume: 174 | Issue: 4 Part 1 | Pages: 1344-1348

10.1097/01.ju.0000173913.41401.67 | PMID 16145416 Get It

Rtt106p is a histone chaperone involved in heterochromatin-mediated silencing
Huang, Shengbing, Zhou, Hui , Katzmann, David J. , Hochstrasser, Mark , Atanasova, Elena, Zhang, Zhiguo

Proceedings of the National Academy of Sciences | September 12, 2005 | Volume: 102 | Issue: 38 | Pages: 13410-13415

10.1073/pnas.0506176102 | PMID 16157874 Get It

Epigenetic inheritance of heterochromatin structure is an important cellular process whose mechanism remains elusive. In this article, we describe the identification of nine enhancers of the silencing defect of a Saccharomyces cerevisiae -PCNA mutant by screening a library of ≈4,700 viable yeast deletion mutants. Of the nine mutants identified, six ( hir1 , hir3 , sas2 , sas4 , sas5 , and sir1 ) were previously known to reduce silencing synergistically with a mutation in Cac1p, the large subunit of chromatin assembly factor 1 (CAF-1). The predicted gene products that are affected in three other mutants ( nam7 , msh2 , and rtt106 ) have not been implicated previously in silencing. Characterization of the rtt106 Δ allele revealed that it synergistically reduced heterochromatin silencing when combined with a mutation in Cac1p but not with a mutation in Asf1p (a histone H3 and H4 chaperone). Moreover, Rtt106p interacted with histones H3 and H4 both in vitro and in vivo , and it displayed a nucleosome assembly activity in vitro . Furthermore, Rtt106p interacts with CAF-1 physically through Cac1p. These biochemical and genetic data indicate that Rtt106p is a previously uncharacterized histone chaperone connecting S phase to epigenetic inheritance.
Endogenous Superantigens Shape Response to Exogenous Superantigens
Rajagopalan, Govindarajan , Singh, Manisha , Sen, Moon M. , Murali, Narayana S. , Nath, Karl A. , David, Chella S.

Clinical and Vaccine Immunology | September 7, 2005 | Volume: 12 | Issue: 9 | Pages: 1119-1122

10.1128/cdli.12.9.1119-1122.2005 | PMID 16148182 Get It

ABSTRACT Endogenous superantigen-mediated thymic negative selection resulted in a paucity of mature T cells bearing T-cell receptor (TCR) Vβ8 in the periphery. Consequently, the magnitude of immune response to exogenous superantigen staphylococcal enterotoxin B, which activates TCR Vβ8 + T cells, was significantly reduced and conferred protection from superantigen-induced mortality.
Combined Open Septorhinoplasty and Functional Endoscopic Sinus Surgery
Lee, Jonathan H., Sherris, David A., Moore, Eric J. , Lee, Jonathan H., Lee, Jonathan H.

Otolaryngology–Head and Neck Surgery | September 7, 2005 | Volume: 133 | Issue: 3 | Pages: 436-440

10.1016/j.otohns.2005.04.010 | PMID 16143196 Get It

OBJECTIVETo compare perioperative and early postoperative complication rates of performing open septorhinoplasty (OSR) and functional endoscopic sinus surgery (FESS) concomitantly or individually.STUDY DESIGN AND SETTINGRetrospective chart review of 55 patients treated at an academic referral center who had undergone combined OSR and FESS. Complication rates for the combined procedures were compared with published complication rates for the individual procedures.RESULTSPatients’ ages ranged from 14 to 77 years (average, 43 years). Among the 55 cases, there were no major complications and 6 (11%) minor complications: 4 cases of cellulitis (7%; previously published risk, 1%‐3%) and 2 cases of postoperative epistaxis (4%).CONCLUSIONOSR and FESS may be performed safely in combination without a clinically significant increased risk of complications.SIGNIFICANCEThe slightly increased risk of cellulitis may warrant the use of intraoperative sinus irrigation and postoperative antibiotic prophylaxis after combined OSR and FESS.
Short-Course Regimens of Artesunate-Fosmidomycin in Treatment of Uncomplicated Plasmodium falciparum Malaria
Borrmann, Steffen , Adégnika, Ayôla Akim , Moussavou, Félicien, Oyakhirome, Sunny, Esser, Gilbert, Matsiegui, Pierre‐Blaise, Ramharter, Michael , Lundgren, Ingrid, Kombila, Maryvonne, Issifou, Saadou, Wiesner, Jochen, Jomaa, Hassan, Hutchinson, David K. , Kremsner, Peter G.

Antimicrobial Agents and Chemotherapy | August 26, 2005 | Volume: 49 | Issue: 9 | Pages: 3749-3754

10.1128/aac.49.9.3749-3754.2005 | PMID 16127049 Get It

ABSTRACT Fosmidomycin is effective against malaria, but it needs to be given for ≥4 days when used alone. We conducted a study of 50 children with Plasmodium falciparum malaria to evaluate the safety and efficacy of consecutively shortened regimens of artesunate-fosmidomycin (1 to 2 mg/kg of body weight and 30 mg/kg of body weight, respectively; doses given every 12 hours). All dosing regimens were well tolerated. Artesunate-fosmidomycin acted rapidly, resulting in consolidated geometric mean parasite and fever clearance times of 24 h and 15 h, respectively. Treatment regimens of ≥2 days led to cure ratios of 100% by day 14 (39/39; 95% confidence interval [95% CI], 91% to 100%). Most importantly, the 3-day regimen achieved 100% cure on day 28 (10/10; 95% CI, 69% to 100%). Treatment with artesunate-fosmidomycin was associated with transient grade I or II neutropenia (absolute neutrophil counts of 750 to 1,200/μl and 400 to 749/μl, respectively) in six or two patients, respectively. Artesunate-fosmidomycin demonstrates the feasibility and potential value of short-course artemisinin-based combination chemotherapy with rapidly eliminated combination partners.
[O2‐03‐01]: Environmental enrichment mitigates cognitive deficits in APP/PS1 transgenic mice
Melnikova, Tatiana , Fadale, Daniel J., Xu, Guilian , Slunt, Hilda H., Gonzales, Victoria, Younkin, Linda H., Younkin, Steven G., Borchelt, David , Savonenko, Alena , Jankowsky, Joanna L.

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_3 | Pages: No page available

10.1016/j.jalz.2005.06.342 Get It

[O2‐01‐01]: Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer's disease: A hazard‐ratio analysis
Thal, Leon J., Thomas, Ronald G. , Grundman, Michael, Doody, Rachelle S., Jin, Shelia , Petersen, Ronald C. , Bennett, David A. , Ferris, Steven H. , Galasko, Douglas , Levey, Allan I.

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_3 | Pages: No page available

10.1016/j.jalz.2005.06.326 Get It

[O1‐04‐04]: Operational criteria for patient recruitment in trials of mild cognitive impairment
Petersen, Ronald , Thomas, Ronald G. , Grundman, Michael, Pfeiffer, Eric, Sano, Mary , Dyck, Christopher H. van , Thal, Leon J., Bennett, David A. , Kaye, Jeffrey , Levey, Allan I.

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_3 | Pages: No page available

10.1016/j.jalz.2005.06.303 Get It

[P‐121]: Resting FDG‐PET in neurologically normal individuals reporting dream enactment behavior: Preclinical dementia with lewy bodies?
Caselli, Richard J. , Reiman, Eric M. , Alexander, Gene E. , Osborne, David, Parish, James M., Krahn, Lois E., Chen, Kewei , Boeve, Bradley F.

Alzheimer's & Dementia | August 25, 2005 | Volume: 1 | Issue: 1S_Part_2 | Pages: No page available

10.1016/j.jalz.2005.06.194 Get It